These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 37883564)

  • 1. Genome editing with retroelements.
    Tang S; Sternberg SH
    Science; 2023 Oct; 382(6669):370-371. PubMed ID: 37883564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-guided DNA insertion with CRISPR-associated transposases.
    Strecker J; Ladha A; Gardner Z; Schmid-Burgk JL; Makarova KS; Koonin EV; Zhang F
    Science; 2019 Jul; 365(6448):48-53. PubMed ID: 31171706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Engineered Cas-Transposon System for Programmable and Site-Directed DNA Transpositions.
    Chen SP; Wang HH
    CRISPR J; 2019 Dec; 2(6):376-394. PubMed ID: 31742433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-based epigenome editing: mechanisms and applications.
    Fadul SM; Arshad A; Mehmood R
    Epigenomics; 2023 Nov; 15(21):1137-1155. PubMed ID: 37990877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome oligopaint via local denaturation fluorescence in situ hybridization.
    Wang Y; Cottle WT; Wang H; Feng XA; Mallon J; Gavrilov M; Bailey S; Ha T
    Mol Cell; 2021 Apr; 81(7):1566-1577.e8. PubMed ID: 33657402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precise and heritable genome editing in evolutionarily diverse nematodes using TALENs and CRISPR/Cas9 to engineer insertions and deletions.
    Lo TW; Pickle CS; Lin S; Ralston EJ; Gurling M; Schartner CM; Bian Q; Doudna JA; Meyer BJ
    Genetics; 2013 Oct; 195(2):331-48. PubMed ID: 23934893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-aided engineering of CRISPR-Cas proteins for enhanced human genome editing.
    Chen Y; Hu Y; Luo S; Wang X; Mao B; Chen Y; Xu J; Li Z; Zhou Q; Li W
    Sci China Life Sci; 2023 Apr; 66(4):883-886. PubMed ID: 36542213
    [No Abstract]   [Full Text] [Related]  

  • 8. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
    Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
    Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The final cut: Cas9 editing.
    Taylor DW
    Nat Struct Mol Biol; 2019 Aug; 26(8):669-670. PubMed ID: 31285603
    [No Abstract]   [Full Text] [Related]  

  • 10. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants.
    Walton RT; Christie KA; Whittaker MN; Kleinstiver BP
    Science; 2020 Apr; 368(6488):290-296. PubMed ID: 32217751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas immunity, DNA repair and genome stability.
    Cubbon A; Ivancic-Bace I; Bolt EL
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30209206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portable CRISPR-Cas9
    Goh YJ; Barrangou R
    Appl Environ Microbiol; 2021 Feb; 87(6):. PubMed ID: 33397707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgene-Free Genome Editing in Nicotiana benthamiana with CRISPR/Cas9 Delivered by a Rhabdovirus Vector.
    Ma X; Li X; Li Z
    Methods Mol Biol; 2023; 2653():173-185. PubMed ID: 36995626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Tools and Resources for CRISPR/Cas Genome Editing.
    Li C; Chu W; Gill RA; Sang S; Shi Y; Hu X; Yang Y; Zaman QU; Zhang B
    Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):108-126. PubMed ID: 35341983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CRISPR AcrIIA5 Potently Inhibits All Cas9 Homologs Used for Genome Editing.
    Garcia B; Lee J; Edraki A; Hidalgo-Reyes Y; Erwood S; Mir A; Trost CN; Seroussi U; Stanley SY; Cohn RD; Claycomb JM; Sontheimer EJ; Maxwell KL; Davidson AR
    Cell Rep; 2019 Nov; 29(7):1739-1746.e5. PubMed ID: 31722192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved CRISPR genome editing using small highly active and specific engineered RNA-guided nucleases.
    Schmidt MJ; Gupta A; Bednarski C; Gehrig-Giannini S; Richter F; Pitzler C; Gamalinda M; Galonska C; Takeuchi R; Wang K; Reiss C; Dehne K; Lukason MJ; Noma A; Park-Windhol C; Allocca M; Kantardzhieva A; Sane S; Kosakowska K; Cafferty B; Tebbe J; Spencer SJ; Munzer S; Cheng CJ; Scaria A; Scharenberg AM; Cohnen A; Coco WM
    Nat Commun; 2021 Jul; 12(1):4219. PubMed ID: 34244505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome Editing in CAR-T Cells Using CRISPR/Cas9 Technology.
    Andreu-Saumell I; Rodriguez-Garcia A; Guedan S
    Methods Mol Biol; 2024; 2748():151-165. PubMed ID: 38070114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Miniature CRISPR-Cas12f1-Mediated Single-Nucleotide Microbial Genome Editing Using 3'-Truncated sgRNA.
    Lee HJ; Kim HJ; Lee SJ
    CRISPR J; 2023 Feb; 6(1):52-61. PubMed ID: 36576897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas for genome editing: Classification, mechanism, designing and applications.
    Bhatia S; Pooja ; Yadav SK
    Int J Biol Macromol; 2023 May; 238():124054. PubMed ID: 36933595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target site selection and remodelling by type V CRISPR-transposon systems.
    Querques I; Schmitz M; Oberli S; Chanez C; Jinek M
    Nature; 2021 Nov; 599(7885):497-502. PubMed ID: 34759315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.